FDA investigates heavy metals in popular period products linked to cancer

The FDA has initiated an investigation into the presence of heavy metals in tampons, following a study by Berkeley researchers that detected harmful substances like lead and arsenic in various products. This investigation will involve a new study to determine if these metals are released during tampon use and an independent review of existing research. The Berkeley study, published in July, tested 30 tampons from 14 major brands, revealing 16 types of heavy metals, raising concerns about potential health risks associated with these products. The FDA emphasized that all tampons sold in the U.S. must meet safety and effectiveness standards, although it remains unclear if heavy metals are specifically tested for during the approval process. The agency acknowledged public concerns regarding tampon safety, particularly after the findings from the 2024 study. However, the study did not assess whether the metals are absorbed into the body during use, leaving a gap in understanding the potential health implications. Heavy metals have been linked to various health issues, including brain damage, kidney disease, and cancer, based on historical exposure studies. The researchers noted that the vagina's highly absorptive tissue could theoretically absorb these metals if they are released while using tampons, leading to systemic exposure. The exact mechanisms by which these metals enter the products remain unclear, but they may originate from the manufacturing process, where chemicals are used for whitening and disinfecting. As millions of women rely on these products, the investigation aims to address safety concerns and ensure that the health risks associated with heavy metal exposure through tampons are thoroughly evaluated. The outcome of this investigation could have significant implications for product safety regulations and consumer awareness regarding menstrual products.